The GERD Devices market was valued at US$ 893.7in 2018, expected to grow at a CAGR of 3.7% during the forecast period from 2019 to 2027.
Market Insights
Increasing prevalence of lifestyle diseases along with new FDA approval for GERD devices will enhance the market growth globally
The global GERD devices market is increasing competently from 2019 to 2027 attributed to the rise of lifestyle diseases, increasing obesity rate in the developed nations, launch & FDA approval of new devices and scopes. Additionally, increased diagnostic procedures along with endoscopy will further spur revenue growth. Esophy X, Linx, and Endocinch endoluminal gastroplication are few invasive methods applied globally. Noninvasive procedures utilized nowadays in the specialty clinics, for e.g. Stretta technique. Barium esophagram, Esophagogastroduodenoscopy, and manometry used in the diagnosis of GERD. The growing aging population in developed countries mainly in the U.S. and Western Europe with increased lifestyle disorders will drive the market globally.
Gastroscopes and esophagoscopes generated maximum revenue in the product segment globally. Increased demand in the diagnostic centers will drive market growth. North America (the U.S) will be the leading regional market for GERD. As per studies by the World Gastroenterology Organization, the prevalence of GERD is high, ranging from 13.0 to 25% and 2 to 6.0% in the Asia Pacific region. The increasing rate of obesity in the United States is one of the key factors driving growth in North America. Additionally, high rates for heartburn symptoms, morning hoarseness, acid reflux, difficulty swallowing, pain in the chest and dry cough in the adult population will drive the need for GERD treatment.
The global GERD market is driven by the rising prevalence of chronic disorders and everyday lifestyle diseases. The high cost of medical devices, cost of routine diagnosis, and less penetration of GERD devices in the developing nations are some of the key factors restraining the overall market growth. Asia Pacific region will show significant growth (mainly India, China, Japan, and Australia) along with improved medical infrastructure and a large pool of adult population with GERD and other reflux related conditions.
Device manufacturers have enhanced their applications globally mainly in the diagnostic centers and hospital industry; the small-scale device manufacturers are also increasing their capacity with low-cost services in Asian countries, South America and Europe region. Advancement in transoral incisionless fundoplication (TIF) procedures, radiofrequency thermal ablation, LINX® reflux management system and other surgical techniques will upsurge the market growth during the forecast period. Factors driving the market growth include increased medical tourism, partnerships of medical technology companies, new GERD device launch, and US FDA approval, increased awareness for GERD conditions, and new technology expansion in the emerging countries.
Key Market Movements:
List of Companies Covered:
This product will be delivered within 2 business days.
Market Insights
Increasing prevalence of lifestyle diseases along with new FDA approval for GERD devices will enhance the market growth globally
The global GERD devices market is increasing competently from 2019 to 2027 attributed to the rise of lifestyle diseases, increasing obesity rate in the developed nations, launch & FDA approval of new devices and scopes. Additionally, increased diagnostic procedures along with endoscopy will further spur revenue growth. Esophy X, Linx, and Endocinch endoluminal gastroplication are few invasive methods applied globally. Noninvasive procedures utilized nowadays in the specialty clinics, for e.g. Stretta technique. Barium esophagram, Esophagogastroduodenoscopy, and manometry used in the diagnosis of GERD. The growing aging population in developed countries mainly in the U.S. and Western Europe with increased lifestyle disorders will drive the market globally.
Gastroscopes and esophagoscopes generated maximum revenue in the product segment globally. Increased demand in the diagnostic centers will drive market growth. North America (the U.S) will be the leading regional market for GERD. As per studies by the World Gastroenterology Organization, the prevalence of GERD is high, ranging from 13.0 to 25% and 2 to 6.0% in the Asia Pacific region. The increasing rate of obesity in the United States is one of the key factors driving growth in North America. Additionally, high rates for heartburn symptoms, morning hoarseness, acid reflux, difficulty swallowing, pain in the chest and dry cough in the adult population will drive the need for GERD treatment.
The global GERD market is driven by the rising prevalence of chronic disorders and everyday lifestyle diseases. The high cost of medical devices, cost of routine diagnosis, and less penetration of GERD devices in the developing nations are some of the key factors restraining the overall market growth. Asia Pacific region will show significant growth (mainly India, China, Japan, and Australia) along with improved medical infrastructure and a large pool of adult population with GERD and other reflux related conditions.
Device manufacturers have enhanced their applications globally mainly in the diagnostic centers and hospital industry; the small-scale device manufacturers are also increasing their capacity with low-cost services in Asian countries, South America and Europe region. Advancement in transoral incisionless fundoplication (TIF) procedures, radiofrequency thermal ablation, LINX® reflux management system and other surgical techniques will upsurge the market growth during the forecast period. Factors driving the market growth include increased medical tourism, partnerships of medical technology companies, new GERD device launch, and US FDA approval, increased awareness for GERD conditions, and new technology expansion in the emerging countries.
Key Market Movements:
- Globally, the global market is growing at a CAGR of 3.7% for the period from 2019 to 2027
- The evident growth factors include increasing prevalence of GERD in the U.S. (prevalence rate is high,7-25%), FDA approval, growing elderly population, and enhanced public awareness related to GERD and other lifestyle diseases
- Market restrictions include high cost of devices and overall treatment, less adoption of GERD devices, unstructured medical coverage for surgical procedures, and less awareness in the overall global GERD devices market
List of Companies Covered:
- Olympus Corporation
- Mederi RF, Inc.
- Medtronic Plc.
- Diversatek Inc
- EndoGastric Solutions
- Pentax Medical
- Torax Medical, Inc.
- Medigus Ltd.
- C.R. Bard, Inc.
- Others
This product will be delivered within 2 business days.
Table of Contents
1. Preface
2. Executive Summary
3. Market Dynamics
4. Global Gastroesophageal Reflux Disease (GERD) Devices Market, by Product Type , 2017-2027 (US$ Mn)
5. Global Gastroesophageal Reflux Disease (GERD) Devices Market, by Procedure Type, 2017-2027 (US$ Mn)
6. Global Gastroesophageal Reflux Disease (GERD) Devices Market, By End User, 2017-2027 (US$ Mn)
7. North America Gastroesophageal Reflux Disease (GERD) Devices Market Analysis, 2017-2027 (US$ Mn)
8. Europe Gastroesophageal Reflux Disease (GERD) Devices Market Analysis, 2017-2027 (US$ Mn)
9. Asia Pacific Gastroesophageal Reflux Disease (GERD) Devices Market Analysis, 2017-2027 (US$ Mn)
10. Rest of the World Gastroesophageal Reflux Disease (GERD) Devices Market Analysis, 2017-2027 (US$ Mn)
11. Company Profiles
List of Figures
List of Tables
Companies Mentioned
- Olympus Corporation
- Mederi RF, Inc.
- Medtronic Plc.
- Diversatek Inc
- EndoGastric Solutions
- Pentax Medical
- Torax Medical, Inc.
- C.R. Bard, Inc.
- MediGus Ltd
- Others